Boston Scientific, Olympus Lead U.S. BPH Market Driven by Prevalent Laser and Transurethral Resection Prostate Procedures
According to a new series of reports on the U.S. market for urological devices by iData Research (www.idataresearch.com), the overall market is well developed and many products are facing average selling price (ASP) declines due to commoditization, except for the benign prostatic hyperplasia (BPH) device market as a result of continued development of new BPH treatments. BPH procedures are segmented into monopolar and bipolar depending on the energy system used. Bipolar vaporization systems were first introduced by Olympus. The company...
View full press release